Follow
Sarah Walker
Sarah Walker
Professor of Medical Statistics and Epidemiology, Oxford University and University College London
Verified email at ndm.ox.ac.uk - Homepage
Title
Cited by
Cited by
Year
Antibody status and incidence of SARS-CoV-2 infection in health care workers
SF Lumley, D O’Donnell, NE Stoesser, PC Matthews, A Howarth, ...
New England Journal of Medicine 384 (6), 533-540, 2021
9662021
Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study
TM Walker, CLC Ip, RH Harrell, JT Evans, G Kapatai, MJ Dedicoat, ...
The Lancet infectious diseases 13 (2), 137-146, 2013
9392013
Diverse Sources of C. difficile Infection Identified on Whole-Genome Sequencing
DW Eyre, ML Cule, DJ Wilson, D Griffiths, A Vaughan, L O'Connor, CLC Ip, ...
New England Journal of Medicine 369 (13), 1195-1205, 2013
7162013
Oral versus intravenous antibiotics for bone and joint infection
HK Li, I Rombach, R Zambellas, AS Walker, MA McNally, BL Atkins, ...
New England Journal of Medicine 380 (5), 425-436, 2019
6462019
Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study
TM Walker, TA Kohl, SV Omar, J Hedge, CDO Elias, P Bradley, Z Iqbal, ...
The Lancet infectious diseases 15 (10), 1193-1202, 2015
6132015
Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis
P Bradley, NC Gordon, TM Walker, L Dunn, S Heys, B Huang, S Earle, ...
Nature communications 6 (1), 10063, 2015
5932015
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
KB Pouwels, E Pritchard, PC Matthews, N Stoesser, DW Eyre, KD Vihta, ...
Nature medicine 27 (12), 2127-2135, 2021
5812021
Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy
Z Jaunmuktane, S Mead, M Ellis, JDF Wadsworth, AJ Nicoll, J Kenny, ...
Nature 525 (7568), 247-250, 2015
5452015
Determinants of survival following HIV-1 seroconversion after the introduction of HAART
Cascade Collaboration
The Lancet 362 (9392), 1267-1274, 2003
5302003
Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial
C Chintu, GJ Bhat, AS Walker, V Mulenga, F Sinyinza, K Lishimpi, ...
The Lancet 364 (9448), 1865-1871, 2004
4782004
Multilocus sequence typing of Clostridium difficile
D Griffiths, W Fawley, M Kachrimanidou, R Bowden, DW Crook, R Fung, ...
Journal of clinical microbiology 48 (3), 770-778, 2010
4592010
Within-host evolution of bacterial pathogens
X Didelot, AS Walker, TE Peto, DW Crook, DJ Wilson
Nature Reviews Microbiology 14 (3), 150-162, 2016
4412016
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes
B Ledergerber, PLATO collaboration
The Lancet 364 (9428), 51-62, 2004
3912004
Effect of Covid-19 vaccination on transmission of alpha and delta variants
DW Eyre, D Taylor, M Purver, D Chapman, T Fowler, KB Pouwels, ...
New England Journal of Medicine 386 (8), 744-756, 2022
3862022
A Candida auris Outbreak and Its Control in an Intensive Care Setting
DW Eyre, AE Sheppard, H Madder, I Moir, R Moroney, TP Quan, ...
New England Journal of Medicine 379 (14), 1322-1331, 2018
3852018
The challenge of antimicrobial resistance: What economics can contribute
LSJ Roope, RD Smith, KB Pouwels, J Buchanan, L Abel, P Eibich, ...
Science 364 (6435), eaau4679, 2019
3822019
Prediction of Staphylococcus aureus antimicrobial resistance by whole-genome sequencing
NC Gordon, JR Price, K Cole, R Everitt, M Morgan, J Finney, AM Kearns, ...
Journal of clinical microbiology 52 (4), 1182-1191, 2014
3772014
Same-day diagnostic and surveillance data for tuberculosis via whole-genome sequencing of direct respiratory samples
AA Votintseva, P Bradley, L Pankhurst, C del Ojo Elias, M Loose, ...
Journal of clinical microbiology 55 (5), 1285-1298, 2017
3722017
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial
DART Trial Team
The Lancet 375 (9709), 123-131, 2010
3662010
Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion
Cascade Collaboration
Aids 20 (5), 741-749, 2006
3462006
The system can't perform the operation now. Try again later.
Articles 1–20